Is there a role for RDTs as we live with COVID-19? An assessment of different strategies

INTRODUCTION: By 2022, high levels of past COVID-19 infections, combined with substantial levels of vaccination and the development of Omicron, have shifted country strategies towards burden reduction policies. SARS-CoV-2 rapid antigen tests (rapid diagnostic tests (RDTs)) could contribute to these...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonnet, Gabrielle, Vassall, Anna, Jit, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852737/
https://www.ncbi.nlm.nih.gov/pubmed/36657797
http://dx.doi.org/10.1136/bmjgh-2022-010690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852737/
https://www.ncbi.nlm.nih.gov/pubmed/36657797
http://dx.doi.org/10.1136/bmjgh-2022-010690

Ejemplares similares